Abstract:Clustered regularly interspaced short palindromic repeats (CRISPR)-based genome editors are powerful tools in biology and hold great promise for the treatment of human diseases. Advanced DNA base editing tools, such as cytosine base editor and adenine base editor, have been developed to correct permanent mistakes in genetic material. However, undesired off-target edits would also be permanent, which poses a considerable risk for therapeutics. Alternatively, base editing at the RNA level is capable of correcting disease-causing mutations but does not lead to lasting genotoxic effects. RNA base editors offer temporary and reversible therapies and have been catching on in recent years. Here, we summarize some emerging RNA editors based on A-to-inosine, C-to-U and U-to-pseudouridine changes. We review the programmable RNA-targeting systems as well as modification enzyme-based effector proteins and highlight recent technological breakthroughs. Finally, we compare editing tools, discuss limitations and opportunities, and provide insights for the future directions of RNA base editing.

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to develop and optimize programmable RNA base - editing techniques to achieve precise modification of disease - related mRNAs. Specifically, the paper focuses on RNA base editing through targeted modification, especially A - to - I, C - to - U and U - to - Ψ (pseudouridine) changes. These techniques can be used to correct point mutations that cause diseases without causing permanent genotoxic effects, thus providing a flexible and reversible treatment option. ### Main Problems 1. **Correcting Single - Nucleotide Mutations**: More than 50% of human pathogenic genetic variations are single - nucleotide mutations. Therefore, efficiently and specifically reversing these pathogenic variations is of great significance for treating hereditary diseases. 2. **Avoiding Permanent Genome Changes**: Unlike DNA editing, RNA editing does not cause permanent genome changes, thereby reducing potential long - term side effects. 3. **Improving Editing Efficiency and Specificity**: Existing RNA editing tools have problems of off - target effects and low efficiency. New techniques and methods need to be developed to improve the efficiency and specificity of editing. 4. **Optimizing Delivery Systems**: The delivery systems of RNA editing tools need to be further optimized to achieve efficient targeted editing in in - vivo applications. ### Solutions The paper summarizes the latest progress in the field of RNA base editing in recent years, including: - **CRISPR - free RNP Systems**: Such as SNAP - ADAR, λN - boxB - ADAR and MCP - ADAR systems. These systems achieve targeted editing of specific transcripts by connecting effector proteins with RNA - binding proteins or peptides. - **CRISPR - based Systems**: Such as Cas13 and Cas9 - derived RNA editing tools. These tools use the CRISPR - Cas system to achieve targeted editing of RNA. - **Protein - only Targeting Systems**: Such as PUF domains and pentatricopeptide - repeat proteins. These modular α - helical repeat proteins can recognize specific RNA sequences. - **RNA - only Targeting Systems**: Such as linear or circular antisense RNAs, small nucleolar RNAs (snoRNAs) and ribozymes. These systems target specific regions through complementary sequences and recruit endogenous RNA - modifying enzymes. ### Future Directions The paper also discusses the challenges faced by the field of RNA base editing and future development directions, including: - **Reducing Off - target Effects**: By optimizing the combination of effector proteins and targeting systems, off - target editing is reduced. - **Improving Editing Efficiency**: Develop new effector proteins and delivery systems to improve the efficiency and specificity of editing. - **Clinical Applications**: Explore the application potential of RNA base editing techniques in disease treatment, especially in the treatment of hereditary diseases and rare diseases. In summary, this paper aims to provide guidance and inspiration for future scientific research and clinical applications by reviewing and analyzing the latest RNA base - editing techniques.

Programmable RNA base editing via targeted modifications

RNA Base Editors: the Emerging Approach of RNA Therapeutics.

Precision RNA base editing with engineered and endogenous effectors

Base editing: precision chemistry on the genome and transcriptome of living cells

Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors

Chemical modifications of adenine base editor mRNA and guide RNA expand its application scope

Programmable System of Cas13-Mediated RNA Modification and Its Biological and Biomedical Applications

A cytosine deaminase for programmable single-base RNA editing

An improved SNAP-ADAR tool enables efficient RNA base editing to interfere with post-translational protein modification

Precise in vivo RNA base editing with a wobble-enhanced circular CLUSTER guide RNA

Programmable RNA base editing with photoactivatable CRISPR-Cas13

Site-directed RNA editing: recent advances and open challenges

Development and application of base editors in bacterial genome editing

Wobble base improves precision in RNA editing

RNA editing with CRISPR-Cas13

[Advances in base editing systems]

CRISPR-Cas9 DNA Base-Editing and Prime-Editing

Base Editing: The Ever Expanding Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Tool Kit for Precise Genome Editing in Plants

EditR: A Method to Quantify Base Editing from Sanger Sequencing

Programmable RNA editing with compact CRISPR–Cas13 systems from uncultivated microbes